Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/24/1998 | US5840560 Glucose kinase from streptococcus pneumoniae |
11/24/1998 | US5840556 Molecular genetic construction of vaccine strains of pasteurellaceae |
11/24/1998 | US5840555 Transcriptional regulatory regions derived from the K18 gene |
11/24/1998 | US5840554 β-Endotoxin expression in pseudomonas fluorescens |
11/24/1998 | US5840547 Bioemulsifiers |
11/24/1998 | US5840545 Immunoglubulins |
11/24/1998 | US5840544 DNA encoding rantes homolog from prostate |
11/24/1998 | US5840543 Fermentation process |
11/24/1998 | US5840542 Method for manufacture of proinsulin with high export yield |
11/24/1998 | US5840541 Recombinant molecule comprising the polyhedrin gene promoter of baculovirus and a structural gene of a rotovirus; biosynthesis of antigenic protein ns28; use in vaccines, viral detection |
11/24/1998 | US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein |
11/24/1998 | US5840539 Polynucleotides encoding a vesicle transport associated proteins |
11/24/1998 | US5840538 Lgt |
11/24/1998 | US5840537 Polynucleotides which identify and encode a human vesicle transport protein (nvtp-1); used in the diagnosis, prevention, and treatment of cancer and immunde disorders |
11/24/1998 | US5840536 Isolated polynucleotide coding for human cytoplasmic signalling protein and hybridizing to complementary polynucleotide coding for protein containing pleckstrin homology domain; preparing pure human protein from culture |
11/24/1998 | US5840535 DNA encoding a zinc ring protein |
11/24/1998 | US5840534 Pure polynucleotide encoding an amino acid sequence; culturing cell containing expression vector; gene family important in cell division; preventing genetic defects |
11/24/1998 | US5840533 Tissue plasminogen activator |
11/24/1998 | US5840532 Recombinant nucleic acid |
11/24/1998 | US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs |
11/24/1998 | US5840530 DNA encoding receptors for the beta-2 chain of human IL-12 |
11/24/1998 | US5840529 Mammalian pro-hormone convertase |
11/24/1998 | US5840528 Overexpression of carotenoids in protoplasts using recombinant dna comprising precursor gene with detectable marker operably linked to regulatory sequences; stability |
11/24/1998 | US5840527 Lung surfactant proteins |
11/24/1998 | US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis |
11/24/1998 | US5840525 P185 receptor implicated in cellular growth |
11/24/1998 | US5840524 Antiinflammatory agents is the culture product from genetic engineered cell; receptor binding activity |
11/24/1998 | US5840523 Using translation initiation region variant (including signal sequence of stii, ompa, phoe, lamb, mbp, and phoa) operably linked to unaltered amino acid coding region; variant has reduced translational strength but increased secretion |
11/24/1998 | US5840522 Recombinant lectins |
11/24/1998 | US5840521 Teta and tetr genes induced by tetracycline and repressed in its absence, expressing a heterologous protein such as ricin a; no penicillin selection markers; highly stable vectors; product of selection only expressed in testing phase |
11/24/1998 | US5840520 Recombinant negative strand RNA virus expression systems |
11/24/1998 | US5840518 Biosynthetic fusion protein comprising a polypeptide segment with a specified amino acid sequence giving signal, promoting transformed cell to secrete fusion protein |
11/24/1998 | US5840517 Process for preparing obesity protein analogs |
11/24/1998 | US5840516 Screening compounds as an inhibitor of excitatory amino acid transport in cells, transforming cell culture for genetic expression, analyzing transformed cell culture |
11/24/1998 | US5840514 Using a fibronectin-depleted substrate and peptide invasion-inducing agent |
11/24/1998 | US5840513 Antibodies directed to pagC peptides for the detection of salmonellae |
11/24/1998 | US5840508 Kit for determining biological antigen comprising detergent having specified structure, modifying reagent, antigen or corresponding antibody |
11/24/1998 | US5840504 Method for separating sex specific molecules and non-sex specific molecules |
11/24/1998 | US5840503 For evaluating efficacy of a therapy associated with cell death in a patient undergoing such a therapy |
11/24/1998 | US5840498 Antibiotic cryptdin peptides and methods of their use |
11/24/1998 | US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy |
11/24/1998 | US5840491 DNA sequence encoding the Machado-Joseph disease gene and uses thereof |
11/24/1998 | US5840489 Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome |
11/24/1998 | US5840483 Method of maintaining a desired recombinant gene in a genetic population of cells |
11/24/1998 | US5840481 Transforming host cells with expression vector; gene product disrupts an essential activity of virus |
11/24/1998 | US5840480 Retrovirus from the HIV group and its use |
11/24/1998 | US5840479 Synthetic human antibody-dna comprising an expression vector with inserted random sequences for the antibody hypervariable regions; clones able secrete specific antibodies or antigen-binding domain |
11/24/1998 | US5840477 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
11/24/1998 | US5840325 Osteogenic devices |
11/24/1998 | US5840317 Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen |
11/24/1998 | US5840316 Desensitization |
11/24/1998 | US5840315 Treating or preventing bovine mastitis |
11/24/1998 | US5840314 Production of streptococcal M protein |
11/24/1998 | US5840313 Antigenic peptides induce antibody-dependent cellular cytotoxicity against hiv |
11/24/1998 | US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity |
11/24/1998 | US5840306 DNA encoding human papillomavirus type 18 |
11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
11/24/1998 | US5840303 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
11/24/1998 | US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
11/24/1998 | US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
11/24/1998 | US5840295 Obtained from injured fish optic nerves; converts interleukin-2 to a dimeric form having oligodendrocyte cytotoxic activity; facilitates regeneration of injured nerves of central nervous system |
11/24/1998 | US5840083 A medical equipment for grafting in mammalian body comprising an amphiphilic coatings having an antibodies receptor molecule conjugated to a supports lipids and membrane protein; ion conductivity |
11/24/1998 | CA2088579C Agents that bind to vcam-1 and uses thereof |
11/24/1998 | CA1340140C Human gamma, delta t cell antigen receptor polypetides and nucleic acids |
11/24/1998 | CA1340139C Particle-stabilized epitopes for standardization and control of immunoassays |
11/23/1998 | CA2232810A1 Novel compounds |
11/23/1998 | CA2232809A1 Novel compounds |
11/23/1998 | CA2232808A1 Novel compounds |
11/23/1998 | CA2232807A1 Novel compounds |
11/23/1998 | CA2230996A1 Novel compounds |
11/23/1998 | CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639) |
11/23/1998 | CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1 |
11/22/1998 | CA2231017A1 A member of the frzb family, frazzled |
11/22/1998 | CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9 |
11/21/1998 | CA2232811A1 Novel def1 |
11/21/1998 | CA2229436A1 A human gene similar to a secreted murine protein sdf5 |
11/21/1998 | CA2224473A1 A novel human gene similar to a secreted murine protein sdf5 |
11/19/1998 | WO1998052038A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening |
11/19/1998 | WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
11/19/1998 | WO1998051824A1 Reagents and methods useful for detecting disease of the urinary tract |
11/19/1998 | WO1998051810A1 Lentivirus-based gene transfer vectors |
11/19/1998 | WO1998051808A1 Methods for producing retroviral vectors with an altered tropism |
11/19/1998 | WO1998051807A1 Episomal expression cassettes for gene therapy |
11/19/1998 | WO1998051806A2 Recovery of transformed plants without selectable markers by nodal culture and enrichment of transgenic sectors |
11/19/1998 | WO1998051805A1 Reagents and methods useful for detecting diseases of the prostate |
11/19/1998 | WO1998051801A1 Gene encoding for systemic acquired resistance in arabidopsis |
11/19/1998 | WO1998051799A1 Novel differentiation inhibitor |
11/19/1998 | WO1998051798A1 Hgf polypeptides and their use in therapy |
11/19/1998 | WO1998051797A1 Human vesicle binding protein |
11/19/1998 | WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein |
11/19/1998 | WO1998051795A1 Double-stranded rna-binding protein |
11/19/1998 | WO1998051794A1 Antimicrobial peptide |
11/19/1998 | WO1998051793A1 Apo-2 RECEPTOR |
11/19/1998 | WO1998051792A1 Fac molecules and uses thereof |
11/19/1998 | WO1998051791A1 Gene causative of rheumatoid arthritis, method for the diagnosis of rheumatoid arthritis, and method for the determination of factors causing rheumatoid arthritis |
11/19/1998 | WO1998051788A2 Method and construct for inhibition of cell migration |
11/19/1998 | WO1998051781A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
11/19/1998 | WO1998051780A2 Method for increasing yields or recombinant proteins |
11/19/1998 | WO1998051707A1 Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants |